Urología
Especialidad
![Foto de Urología](/img/noimage.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (33)
2024
-
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
Cardiovascular Diabetology, Vol. 23, Núm. 1
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2023
-
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Molecular cancer, Vol. 22, Núm. 1, pp. 119
-
Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones
Antibiotics, Vol. 12, Núm. 5
-
Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma
Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293
2022
-
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability
Antibiotics, Vol. 11, Núm. 5
-
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer
Oncogenesis, Vol. 11, Núm. 1
2021
-
Clinical implications of (Pro)renin receptor (prr) expression in renal tumours
Diagnostics, Vol. 11, Núm. 2
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
2020
-
1H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer
Journal of Proteome Research, Vol. 19, Núm. 6, pp. 2419-2428
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2018
-
Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer
Cell Death and Disease, Vol. 9, Núm. 10
-
Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression
Journal of Extracellular Vesicles, Vol. 7, Núm. 1
-
PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth
Cancer Research, Vol. 78, Núm. 2, pp. 399-409
-
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Cell, Vol. 174, Núm. 6, pp. 1559-1570.e22
2017
-
Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients
PLoS ONE, Vol. 12, Núm. 8
-
MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Nature, Vol. 547, Núm. 7661, pp. 109-113
2016
-
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis
Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656
-
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer
Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846